Search

Search Constraints

You searched for: Author/Creator Frerix, Marc

Search Results

2. Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group. (11th May 2017)

3. SAT0254 VASODILATOR THERAPY IN THE LONG TERM PREVENTION OF MYOCARDIAL MANIFESTATIONS IN SYSTEMIC SCLEROSIS (SSC): RESULTS FROM DESSCIPHER INCEPTION COHORT STUDY. (June 2019)

4. The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index. Issue 1 (12th September 2016)

5. Update of EULAR recommendations for the treatment of systemic sclerosis. Issue 8 (9th November 2016)

8. Common measure of quality of life for people with systemic sclerosis across seven European countries: a cross-sectional study. Issue 7 (20th February 2018)

9. Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the DeSScipher inception cohort study. Issue 11 (November 2019)

10. Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the DeSScipher inception cohort study. Issue 11 (7th August 2019)